DK485888A - Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf - Google Patents

Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf

Info

Publication number
DK485888A
DK485888A DK485888A DK485888A DK485888A DK 485888 A DK485888 A DK 485888A DK 485888 A DK485888 A DK 485888A DK 485888 A DK485888 A DK 485888A DK 485888 A DK485888 A DK 485888A
Authority
DK
Denmark
Prior art keywords
hmg
preparing
procedure
coa reductase
reductase inhibitor
Prior art date
Application number
DK485888A
Other languages
Danish (da)
English (en)
Other versions
DK485888D0 (da
Inventor
George D Hartman
Robert L Smith
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK485888D0 publication Critical patent/DK485888D0/da
Publication of DK485888A publication Critical patent/DK485888A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
DK485888A 1987-09-02 1988-09-01 Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf DK485888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9235487A 1987-09-02 1987-09-02

Publications (2)

Publication Number Publication Date
DK485888D0 DK485888D0 (da) 1988-09-01
DK485888A true DK485888A (da) 1989-03-03

Family

ID=22232825

Family Applications (1)

Application Number Title Priority Date Filing Date
DK485888A DK485888A (da) 1987-09-02 1988-09-01 Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf

Country Status (8)

Country Link
EP (1) EP0306264A3 (ja)
JP (1) JPH0196152A (ja)
KR (1) KR890005080A (ja)
AU (1) AU606203B2 (ja)
DK (1) DK485888A (ja)
IL (1) IL87600A0 (ja)
PT (1) PT88364A (ja)
ZA (1) ZA886468B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI893004A (fi) * 1988-06-29 1989-12-30 Merck & Co Inc 5-oxygenerade hmg-coa-reduktas -inhibitorer.
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents
US5001148A (en) * 1989-06-07 1991-03-19 E. R. Squibb & Sons, Inc. Mevinic acid derivatives
EP0415488B1 (en) * 1989-08-31 1994-04-20 Merck & Co. Inc. 7-Substituted HMG-COA reductase inhibitors
US5025017A (en) * 1989-09-28 1991-06-18 E. R. Squibb & Sons, Inc. Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
GB9007738D0 (en) * 1990-04-05 1990-06-06 British Bio Technology Compounds
MY106564A (en) * 1990-07-06 1995-06-30 Squibb & Sons Inc Sulfur-substituted mevinic acid derivatives.
US5159104A (en) * 1991-05-01 1992-10-27 Merck & Co., Inc. Process to simvastatin ester
US9107983B2 (en) 2010-10-27 2015-08-18 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising statins
US8877221B2 (en) 2010-10-27 2014-11-04 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
WO2012170417A2 (en) 2011-06-06 2012-12-13 Warsaw Orthopedic, Inc. Methods and compositions to enhance bone growth comprising a statin
CN111225672B (zh) 2017-10-16 2023-09-29 清华大学 甲羟戊酸通路抑制剂及其药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294846A (en) * 1979-09-21 1981-10-13 Merck & Co., Inc. Hypocholesteremic fermentation products and products of preparation
EP0204287A3 (en) * 1985-06-04 1987-07-01 Merck & Co. Inc. Process for the preparation of hmg-coa reductase inhibitors with a 3,5-dihydroxypentanoate subunit
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
FI893004A (fi) * 1988-06-29 1989-12-30 Merck & Co Inc 5-oxygenerade hmg-coa-reduktas -inhibitorer.

Also Published As

Publication number Publication date
IL87600A0 (en) 1989-01-31
KR890005080A (ko) 1989-05-11
ZA886468B (en) 1989-04-26
PT88364A (pt) 1989-07-31
AU2175088A (en) 1989-03-16
EP0306264A3 (en) 1989-08-16
EP0306264A2 (en) 1989-03-08
DK485888D0 (da) 1988-09-01
JPH0196152A (ja) 1989-04-14
AU606203B2 (en) 1991-01-31

Similar Documents

Publication Publication Date Title
DK370486A (da) Hmg-coa-reduktaseinhibitor og fremgangsmaade til fremstilling deraf
JPS6426535A (en) Novel hmg-coa reductase inhibitor
PH25350A (en) PHOSPHOROUS-CONTAINING HMG-CoA REDUCTASE INHIBITORS
EP0251625A3 (en) Novel hmg-coa reductase inhibitors
DK226888D0 (da) Steroid 5-alfa-reduktase inhibitor
DK10289D0 (da) Fremgangsmaade og praeparater til forebyggelse af ulcus
EP0403487A4 (en) Novel hmg-coa reductase inhibitors
DK277388D0 (da) Phosphorholdige hmg-coa-reduktase-inhibitorer, mellemprodukter og fremgangsmaade
DK134288D0 (da) Kemo-radio-immuno-konjugat og fremgangsmaade til fremstilling heraf
DK485888A (da) Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf
EP0323866A3 (en) Novel hmg-coa reductase inhibitors
NO901272D0 (no) Sammensetning og fremgangsmaate for fjerning av sulfider.
DK486088D0 (da) Hmg-coa reduktaseinhibitor og fremgangsmaade til fremstilling deraf
DE69008277D1 (de) 7-Subsituierte HMG-CoA-Reduktase-Inhibitoren.
DK251087A (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
DK422989D0 (da) Quinolin- og pyridinankre for hmg-coa-reductaseinhibitorer
EP0320052A3 (en) Intermediates and processes for 6-carboxy hmg-coa reductase inhibitors
DK25388D0 (da) Kondenserede pyrazolderivater og fremgangsmaade til fremstilling heraf
EP0468974A4 (en) Novel hmg-coa reductase inhibitors
IE871654L (en) Novel hmg-coa reductase inhibitors
IE861739L (en) Hmg-coa reductase inhibitors
IE882652L (en) NOVEL HMG-CoA REDUCTASE INHIBITORS
IE822652L (en) HMG-CoA REDUCTASE INHIBITORS
ZA894895B (en) 5-oxygenated hmg-coa reductase inhibitors
DK577688A (da) Fastgoerelsessorgan og fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment